¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"serum response factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
macrophage arming factor
Å«Æ÷½Ä¼¼Æ÷¹«ÀåÀÎÀÚ, ´ë½Ä¼¼Æ÷¹«ÀåÀÎÀÚ
macrophage chemotactic factor
Å«Æ÷½Ä¼¼Æ÷ÈÇнò¸²ÀÎÀÚ, ´ë½Ä¼¼Æ÷ÈÇнò¸²ÀÎÀÚ
macrophage colony-stimulating factor
Å«Æ÷½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ, ´ë½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ
macrophage migration inhibitory factor
Å«Æ÷½Ä¼¼Æ÷À̵¿ÀúÁöÀÎÀÚ, ´ë½Ä¼¼Æ÷À̵¿ÀúÁöÀÎÀÚ
macrophage-activating factor
Å«Æ÷½Ä¼¼Æ÷Ȱ¼ºÀÎÀÚ, ´ë½Ä¼¼Æ÷Ȱ¼ºÀÎÀÚ
macrophage-derived growth factor
Å«Æ÷½Ä¼¼Æ÷À¯·¡¼ºÀåÀÎÀÚ, ´ë½Ä¼¼Æ÷À¯·¡¼ºÀåÀÎÀÚ
nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
neutron kerma factor
Áß¼ºÀÚÄ¿¸¶°è¼ö
neutrophil chemotactic factor
Áß¼º±¸ÈÇÐÁÖ¼ºÀÎÀÚ, È£Áß±¸½ò¸²ÀÎÀÚ
occupancy factor
°ÅÁÖ°è¼ö
obliquity factor
±â¿ï±â°è¼ö
output factor
Ãâ·ÂÀÎÀÚ
oxygen gain factor
»ê¼ÒÀ̵æ°è¼ö
plasma coagulation factor
Ç÷ÀåÀÀ°íÀÎÀÚ
plasma thromboplastin factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
neutron kerma factor
Áß¼ºÀÚÄ¿¸¶°è¼ö
neutrophil chemotactic factor
È£Áß±¸ÁÖ¼ºÀÎÀÚ, È£Áß±¸½ò¸²ÀÎÀÚ
obliquity factor
±â¿ï±â°è¼ö
occupancy factor
°ÅÁÖ°è¼ö
output factor
Ãâ·ÂÀÎÀÚ
oxygen gain factor
»ê¼ÒÀ̵æ°è¼ö
phantom scatter factor
ÆÒÅè»ê¶õ°è¼ö
plasma coagulation factor
Ç÷ÀåÀÀ°íÀÎÀÚ
plasma thromboplastin factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ
platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ÃËÁø¿äÀÎ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
hageman factor
ÇϰԸ¸ ÀÎÀÚ, Hageman ÀÎÀÚ
hematopoietic growth factor
Á¶Ç÷¼ºÀåÀÎÀÚ
hemorrhagic diathesis,clotting factor abnormalities
ÀÀ°íÀÎÀÚ ÀÌ»ó
hepatocyte growth factor
°£¼¼Æ÷¼ºÀåÀÎÀÚ
histamine sensitizing factor =HSF
È÷½ºÅ¸¹Î°¨ÀÛÀÎÀÚ(¡ÊïíÂì×í).
homologous restriction factor
µ¿Á¾Á¦ÇÑÀÎÀÚ
hyperglycemic glycogenolytic factor
°íÇ÷´ç¼º ´ç¿øºÐÇØ(¼º) ÀÎÀÚ.
hypothalamic releasing factor
½Ã»óÇϺÎÀ¯¸®ÀÎÀÚ(ë¤×ãì×í).
hypothalamic releasing factor
½Ã»óÇϺιæÃâÀÎÀÚ.
hypothalamus releasing factor
½Ã»óÇϺÎÀ¯¸®ÀÎÀÚ.
inhibition(-tory) factor, macrophage migration
´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ
intensity factor
°µµÀÎÀÚ
plasma coagulation factor
Ç÷ÀåÀÀ°íÀÎÀÚ
plasma factor
Ç÷ÀåÀÎÀÚ(úìíìì×í), ÇöóÁÀÎÀÚ.
plasma factor
Ç÷ÀåÀÎÀÚ(úìíìì×í), ÇöóÁÀÎÀÚ(¡ì×í)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
mixed lymphocyte response(MLR)
motor response
¿îµ¿¼º ¹ÝÀÀ(¡àõÚãëë).
occulovestibular response
oculocephalic response
partial response
À¯È¿, ºÎºÐ°üÇØ
placebo response
Çö󼼺¸¹ÝÀÀ, À§<°¡>¾à¹ÝÀÀ.
placebo response
Çö󼼺¸¹ÝÀÀ, À§¾à¹ÝÀÀ, ¼ÓÀÓ¾à¹ÝÀÀ.
positive placebo response
Çö󼼺¸Ä¡·á È¿°ú.
pressure response
À½¾Ð¹ÝÀÀ(ëåäâÚãëë).
primary antibody response
ÀÏÂ÷Ç×ü¹ÝÀÀ
primary immune response
ÀÏÂ÷¸é¿ª¹ÝÀÀ(¡Øóæ¹Úãëë).
primary immune response
ÀÏÂ÷¸é¿ª¹ÝÀÀ(¡Øóæ¹Úãëë).
radiation response
¹æ»ç¼±¹ÝÀÀ
recruiting response
µ¿¿ø¹ÝÀÀ(ÔÑê¬Úãëë).
response curve
¹ÝÀÀ°î¼±
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½